COVID-19 serology/antibody testing is covered by TRICARE only when medically necessary and when the results of the test will impact the clinical management of the beneficiary. For example, if a beneficiary exhibits late symptoms or sequelae of COVID-19, testing would be covered.
It is not covered for general screening in asymptomatic individuals, to determine immunity from past infection, or for return to work/school purposes.
For further guidance on COVID-19 serology/antibody testing, refer to CDC guidance on the proper use of COVID-19 serology testing. The Military Health System (MHS) follows CDC guidelines, while most civilian healthcare plans follow the CARES act.
